Back to PollNow

Back to companies

Kura Oncology, Inc.

KURAUSNASDAQPharmaceuticals & Healthcare

Kura Oncology, Inc.

Revenue

$67.5mn

YoY +25.2%

Operating income

-$303.6mn

FY2025

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API